TOYO Corporation (TYO:8151)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	33,128	35,368	29,168	28,621	28,592	24,422
Market Cap Growth	-14.45%	21.25%	1.91%	0.10%	17.08%	-7.05%
Enterprise Value	31,509	29,657	24,305	20,940	16,722	16,578
Last Close Price	1538.00	1580.79	1225.21	1089.22	1043.97	830.54
PE Ratio	37.43	14.02	19.02	14.92	16.49	16.98
Forward PE	16.66	16.17	16.17	16.17	16.17	16.17
PS Ratio	1.03	1.01	1.03	1.08	1.22	1.06
PB Ratio	1.17	1.26	1.03	0.97	0.96	0.81
P/TBV Ratio	1.29	1.39	1.08	1.01	0.99	0.84
P/FCF Ratio	7.97	13.95	-	-	4.95	14.32
P/OCF Ratio	7.16	8.61	-	15.68	4.73	11.46
PEG Ratio	-	2.32	2.32	2.32	2.32	2.32
EV/Sales Ratio	0.98	0.85	0.86	0.79	0.71	0.72
EV/EBITDA Ratio	12.00	6.57	10.37	6.40	6.21	7.48
EV/EBIT Ratio	22.14	8.81	16.51	8.98	9.69	13.26
EV/FCF Ratio	7.58	11.70	-	-	2.89	9.72
Debt / Equity Ratio	0.14	0.07	-	-	-	-
Debt / EBITDA Ratio	1.52	0.44	-	-	-	-
Debt / FCF Ratio	0.96	0.79	-	-	-	-
Asset Turnover	0.74	0.89	0.69	0.66	0.64	0.67
Inventory Turnover	4.54	4.65	4.34	5.41	6.57	7.25
Quick Ratio	1.11	1.17	0.84	1.50	4.21	3.80
Current Ratio	1.68	1.86	1.54	2.32	4.95	4.39
Return on Equity (ROE)	3.08%	8.94%	5.32%	6.49%	5.78%	4.78%
Return on Assets (ROA)	2.05%	5.32%	2.26%	3.62%	2.94%	2.26%
Return on Capital (ROIC)	2.65%	7.20%	3.19%	4.93%	3.60%	2.60%
Return on Capital Employed (ROCE)	4.90%	11.50%	5.10%	6.80%	5.00%	4.00%
Earnings Yield	2.73%	7.13%	5.26%	6.71%	6.07%	5.89%
FCF Yield	12.55%	7.17%	-5.13%	-18.56%	20.22%	6.99%
Dividend Yield	4.77%	4.30%	4.41%	4.59%	4.12%	4.58%
Payout Ratio	164.45%	50.56%	78.36%	57.95%	56.57%	59.60%
Buyback Yield / Dilution	2.27%	1.83%	4.05%	3.28%	0.39%	0.21%
Total Shareholder Return	7.04%	6.13%	8.46%	7.87%	4.51%	4.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.